• Contraindications for tislelizumab use

  Tislelizumab (a PD-1 inhibitor) is contraindicated mainly in patients with hypersensitivity to the drug components, active autoimmune diseases, uncont···【Read More】

  Update: 2026-02-27Source: Haiou HealthViews: 197

• Fruquintinib Capsules, a Drug for Metastatic Colorectal Cancer, Approved for Marketing

  September 5, 2018, the National Medical Products Administration (NMPA) approved the marketing of Fruquintinib Capsules (Elunate), a therapeutic drug f···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 144

• What medicinal products is fruquintinib commonly used in combination with?

  Due to the risk of drug-drug interactions, the concomitant use of this product must follow the physician’s instructions strictly.Patients must not use···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 143

• What dosage forms and strengths does fruquintinib have?

  Fruquintinib capsules are available in two strengths:1 mg per capsule and 5 mg per capsule.【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 178

• What should I do in case of fruquintinib overdosage?

  The specific adverse effects caused by overdosage of this product are currently unknown.If overdosage is suspected, stop taking the medication immedia···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 152

• What should I do if I miss a dose of fruquintinib?

  If you occasionally forget to take a dose on time, do not double the dose or take an extra dose the next day to make up for the missed one. Take the n···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 179

• How should fruquintinib be stored?

  This product should be stored sealed below 30°C. Keep this product out of the reach of children to prevent accidental ingestion.【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 178

• What precautions should be taken when using this product?

  If symptoms affecting attention and reaction occur during treatment with this product, it is recommended that the patient avoid driving or operating m···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 145

• How Much Does One Treatment Course of Fruquintinib Cost?

  The cost of one treatment course of Fruquintinib is affected by factors such as dosage, regional differences and medical insurance policies, usually r···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 143

• Online Pharmacies for Fruquintinib

  Fruquintinib is a prescription anti-tumor drug. It can only be purchased with a doctor’s prescription and must not be obtained through unregulated cha···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 163

• Price of Fruquintinib Capsules

  The price of Fruquintinib Capsules is affected by factors such as specifications, regions and medical insurance policies. Generally, the price per box···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 134

• Price of Fruquintinib Capsules

  The price of Fruquintinib Capsules varies depending on drug specifications, regions, and policies of medical institutions or pharmacies. A box general···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 151

• Special Populations Dosage and Administration of Fruquintinib

  Fruquintinib is an oral small‑molecule anti‑angiogenic targeted drug, mainly used for the treatment of advanced colorectal cancer. The use of fruquint···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 160

• Approval of Revelumide Tablets, a Class 1 New Drug from Hengrui Medicine, for Market Launch

  On June 30, 2022, the National Medical Products Administration (NMPA) approved the market launch of Revelumide Tablets (brand name: Airuien), a Class ···【Read More】

  Update: 2026-02-25Source: Haiou HealthViews: 200

• How long does it generally take for Relugolix Tablets to take effect after administration?

  Following a single oral dose of 240 mg Relugolix in patients with prostate cancer, the mean time to reach peak plasma concentration is approximately 7···【Read More】

  Update: 2026-02-25Source: Haiou HealthViews: 191